Janet Dancey

Researcher Next ID · RN-004329

Researcher · Medicine

Kingston, Canada

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Lung Cancer Treatments and Mutations

Cancer Genomics and Diagnostics

PI3K/AKT/mTOR signaling in cancer

Colorectal Cancer Treatments and Studies

HER2/EGFR in Cancer Research

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30074-8
RECIST 1.1—Update and clarification: From the RECIST committee
European Journal of Cancer · 2016 · https://doi.org/10.1016/j.ejca.2016.03.081
Response assessment criteria for brain metastases: proposal from the RANO group
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)70057-4
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
European Journal of Cancer · 2008 · https://doi.org/10.1016/j.ejca.2008.10.026
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Journal of Clinical Oncology · 2000 · https://doi.org/10.1200/jco.2000.18.10.2095

No projects listed.